Eagle Pharmaceuticals Founder, President & CEO Scott Tarriff Named EY Entrepreneur Of The Year® 2016 New Jersey Region

WOODCLIFF LAKE, N.J.–(BUSINESS WIRE)–Eagle Pharmaceuticals (NASDAQ:EGRX) is pleased to announce that Founder,
President and CEO Scott Tarriff received the EY Entrepreneur Of The
Year® 2016 Award in the Specialty Pharmaceutical category in New Jersey.
This year marks the 30^th anniversary of the EY Entrepreneur
Of The Year Award program. The award recognizes outstanding
entrepreneurs who demonstrate excellence and extraordinary success in
such areas as innovation, financial performance, and personal commitment
to their businesses and communities. Mr. Tarriff was selected by an
independent panel of judges, and the award was presented at a special
gala event at the Hyatt Regency, New Brunswick on June 23, 2016.
“I am honored to have been selected as a winner of the EY Entrepreneur
Of The Year award, alongside other outstanding New Jersey
professionals,” said Scott Tarriff, President and CEO of Eagle
Pharmaceuticals. “This recognition is especially gratifying, given
Eagle’s accomplishments since going public in 2014. In the past two
years, we have transitioned to a profitable specialty pharmaceutical
company, focusing on critical care, orphan diseases and oncology. I am
proud of the Eagle team and its commitment to advancing the safety,
convenience and delivery of injectable medicines that improve people’s
lives,” he continued. Eagle Pharmaceuticals currently has four in-market
products and a deep pipeline of pharmaceuticals under development.
Since 1986, EY has honored entrepreneurs whose ingenuity, spirit of
innovation and discipline have propelled their companies’ success,
invigorated their industries, and benefited their communities. Now in
its 30^th year, the program has honored the inspirational
leadership of such entrepreneurs as Howard Schultz of Starbucks Coffee
Company, Robert Unanue of Goya Foods, and Mindy Grossman of HSN. Recent
U.S. national winners include Reid Hoffman and Jeff Weiner of LinkedIn;
Hamdi Ulukaya, founder of Chobani; and 2015 winners Andreas Bechtolsheim
and Jayshree Ullal of Arista Networks.
As a New Jersey award winner, Mr. Tarriff is now eligible for
consideration for the Entrepreneur Of The Year 2016 national program.
Award winners in several national categories, as well as the
Entrepreneur Of The Year National Overall Award winner, will be
announced at the Entrepreneur Of The Year National Awards gala in Palm
Springs, California, on November 19, 2016. The awards are the
culminating event of the Strategic Growth Forum^TM, the
nation’s most prestigious gathering of high-growth, market-leading
companies. The U.S. Entrepreneur Of The Year Overall Award winner then
moves on to compete for the World Entrepreneur Of The Year Award in
Monaco, June 2017.
About Eagle Pharmaceuticals, Inc.
Eagle is a specialty pharmaceutical company focused on developing and
commercializing injectable products that address the shortcomings, as
identified by physicians, pharmacists and other stakeholders, of
existing commercially successful injectable products. Eagle’s strategy
is to utilize the FDA’s 505(b)(2) regulatory pathway. Additional
information is available on the company’s website at www.eagleus.com.
About EY Entrepreneur Of The Year®
EY Entrepreneur Of The Year is the world’s most prestigious business
award for entrepreneurs. The unique award makes a difference through the
way it encourages entrepreneurial activity among those with potential
and recognizes the contribution of people who inspire others with their
vision, leadership and achievement. As the first and only truly global
award of its kind, Entrepreneur Of The Year celebrates those who are
building and leading successful, growing and dynamic businesses,
recognizing them through regional, national and global awards programs
in more than 145 cities in more than 60 countries.
About EY
EY is a global leader in assurance, tax, transaction and advisory
services. EY refers to the global organization, and may refer to one or
more, of the member firms of Ernst & Young Global Limited, each of which
is a separate legal entity.